Clinical Trials Logo

Clinical Trial Summary

A study to characterize children and adults with influenza like symptoms and to determine risk factors for severe disease and death among those with H1N1.


Clinical Trial Description

In March 2009, a new influenza A virus, novel H1N1 (commonly referred to as "swine flu"), began causing an increase in reports of influenza-like illness in North America. Although the virus subsequently spread rapidly around the world, the earliest reported outbreak of cases occurred in Mexico City, which is seen as the epicenter of the influenza pandemic, the world's first in 40 years.

Many questions remain about this emerging pandemic and the virus causing it, the answers to which could better inform patient management and policy decisions both in Mexico and internationally. Sparse reliable clinical research data have been collected on the natural history of the disease, on the risk factors associated with severe disease, or on the severity of this pandemic influenza as compared to seasonal influenzas. This study is an initial step to better characterize individuals in Mexico who develop influenza-like illness (including illness caused by novel H1N1), to describe the clinical management of those individuals, and to assess their short-term outcome. The planned data collection will provide timely information to inform policy and guidelines for the local populations and governments involved and may also be used to design future ancillary studies of this influenza virus and/or studies of other emerging infectious diseases.

The purpose of this observational study is to characterize individuals in Mexico who seek medical care for influenza-like illness (ILI) and to describe clinical course over a period of at least 28 days after enrollment. ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01418287
Study type Observational
Source Mexican Infectious Disease Network
Contact
Status Completed
Phase N/A
Start date April 2010
Completion date May 2014

See also
  Status Clinical Trial Phase
Completed NCT02302924 - Evaluation of Psychometric Testing Properties of Severity Symptom Grading Scale of Influenza Infection: Flu-PRO Stage III
Completed NCT00981513 - Direct and Indirect Benefits of Influenza Vaccination in Schools and Households Phase 4
Completed NCT03274310 - FluSAFE: Flu SMS Alerts to Freeze Exposure N/A
Completed NCT03695432 - Probiotic and Influenza Vaccination to Reducing Influenza-like Illness Incident in Elderly Phase 4
Active, not recruiting NCT03734237 - A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD Phase 4
Completed NCT04646980 - Biobran/MGN-3 Increases Innate Resistance and Reduces the Incidence of Influenza-like Illnesses N/A
Completed NCT03599739 - Adjuvanted Influenza Vaccination Year 2 Follow-On Survey
Completed NCT02979730 - Impact of Rapid Flu Testing in BMC ED N/A
Completed NCT03454009 - Kent State University / Price Chopper Employee Wellness Study N/A
Active, not recruiting NCT01687816 - Nasal Specimen Collection Study in Patients With ILI and/or ARI in an Outpatient Setting N/A
Completed NCT00448773 - REDucing Influenza Among University Students, University of California at Berkeley Phase 4
Completed NCT03656198 - Non-specific Effects of Rabies Vaccine Phase 4
Completed NCT02882100 - Adjuvanted Influenza Vaccination in U.S. Nursing Homes Phase 4